SYNAGIS
Google image searchProduct monograph
Active ingredient
palivizumab, 100 MG/ML
DIN: 02438364
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: 1ML SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: ASTRAZENECA CANADA INC
Date: 29-APR-2022
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BD — Antiviral monoclonal antibodies (ATC, ATC/DDD)
- J06BD01 — PALIVIZUMAB (ATC/DDD)
Reference brand drug: Synagis
External Links for Synagis
Search on Google
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find synagis photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.